MedTrace Logo

The Creative Team Member: A Study of the Influence of AI Integration Timing on Brainstorming and Ideation

NCT07693803 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2026-07-14

No results posted yet for this study

Summary

This study aims to examine how the timing of artificial intelligence (AI) integration during group brainstorming activities affects the creativity and ideation of participants. Undergraduate student participants will be randomly allocated into teams of four to complete a structured 12-minute brainstorming task. The study utilizes a three-group experimental design to compare three conditions: no AI access, AI access from the outset of the session, and AI access introduced halfway through the session. The standardized generative AI tool used is ChatGPT Pro. The creative output produced by each group will be evaluated by a panel of independent expert judges using the Consensual Assessment Technique (CAT).

Conditions

  • Creativity

Interventions

BEHAVIORAL

Artificial Intelligence First (Early Integration)

The introduction of ChatGPT Pro (GPT-4o architecture) at the beginning (minute 0) of a 12-minute group brainstorming session. A single prompt containing the scenario is submitted to generate an initial set of ideas, with no further back-and-forth dialogue permitted. This single artificial intelligence output serves as the baseline for the team's subsequent human ideation.

BEHAVIORAL

Artificial Intelligence Last (Late Integration)

The introduction of ChatGPT Pro (GPT-4o architecture) at the midpoint (minute 6) of a 12-minute group brainstorming session. A single prompt containing both the scenario and the team's already-generated human ideas is submitted, with no further back-and-forth dialogue permitted. This single artificial intelligence output is used to guide the team's human ideation for the remaining 6 minutes.

Sponsors & Collaborators

Principal Investigators

  • Mohit Bhandari, MD, PhD, FRCSC · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-20
Primary Completion
2026-08-15
Completion
2026-09-15

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07693803 on ClinicalTrials.gov